Unicycive Therapeutics Inc. Gains 153.06%
Unicycive Therapeutics Inc. (UNCY:NASDAQ) soared at $1.24, a gain of 153.1%. On Mon, Mar 06, 2023, UNCY:NASDAQ touched a New 2-Week High of $1.24. The stock appeared on our News Catalysts scanner on Mon, Mar 06, 2023 at 08:48 AM in the 'INVESTOR UPDATE' category. From Tue, Feb 21, 2023, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Mon, Mar 06, 2023 at $1.63 with a volume of 102M+.
About Unicycive Therapeutics Inc. (UNCY:NASDAQ)
Unicycive Therapeutics Inc is a biotechnology company dedicated towards developing treatments for certain medical conditions. It is focusing on kidney diseases.
Top 10 Gainers:
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 159.32%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 153.06%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 95.02%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 92.86%
- Genelux Corporation (GNLX:NASDAQ), 60.42%
- Orchestra BioMed Holdings Inc Com (OBIO:NASDAQ), 58.09%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 54.64%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 53.92%
- BridgeBio Pharma, Inc. (BBIO:NASDAQ), 51.98%
- Troika Media Group Inc. (TRKA:NASDAQ), 48.64%